Ardelyx (ARDX) Non-Current Assets (2013 - 2026)

Ardelyx (ARDX) reported Non-Current Assets of $122.6 million for Q1 2026, up 25.78% on a YoY basis from $97.5 million in Q1 2025, and up 2.81% quarter-over-quarter from $119.3 million in Q4 2025.

Ardelyx (ARDX) Non-Current Assets (2013 - 2026) Analysis & Trends

Ardelyx has reported Non-Current Assets for 14 years, with the latest figure at $122.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets rose 25.78% year-over-year to $122.6 million; the trailing twelve-month figure through Mar 2026 stood at $475.3 million (up 39.37% YoY), and the FY2025 full-year result was $119.3 million, up 50.42% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $122.6 million, up from $119.3 million in the prior quarter.
  • The five-year high for Non-Current Assets was $122.6 million in Q1 2026, with the low at $15.2 million in Q1 2022.
  • Historically, Non-Current Assets has averaged $70.2 million across 5 years, with a median of $79.3 million in 2024.
  • Annual changes were most pronounced in 2022 — Non-Current Assets retreated 5.34% — and 2023, when it jumped 229.13%.
  • Ardelyx's Non-Current Assets stood at $36.5 million in 2022, then jumped by 41.15% to $51.5 million in 2023, then jumped by 54.08% to $79.3 million in 2024, then soared by 50.42% to $119.3 million in 2025, then increased by 2.81% to $122.6 million in 2026.
  • The last three Non-Current Assets figures came in at $122.6 million (Q1 2026), $119.3 million (Q4 2025), and $118.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 122.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 122.64 Mn
Dec 31, 2025 119.29 Mn
Sep 30, 2025 118.19 Mn
Jun 30, 2025 115.20 Mn
Mar 31, 2025 97.50 Mn
Dec 31, 2024 79.30 Mn
Sep 30, 2024 83.77 Mn
Jun 30, 2024 80.47 Mn
Mar 31, 2024 84.44 Mn
Dec 31, 2023 51.47 Mn
Sep 30, 2023 48.16 Mn
Jun 30, 2023 49.09 Mn
Mar 31, 2023 49.97 Mn
Dec 31, 2022 36.46 Mn
Sep 30, 2022 24.80 Mn
Jun 30, 2022 17.50 Mn
Mar 31, 2022 15.18 Mn
Dec 31, 2021 16.26 Mn
Sep 30, 2021 17.47 Mn
Jun 30, 2021 18.49 Mn